Filing Flows › Revolution Medicines (RVMD) › Recalls, complaints & regulation
Revolution Medicines (RVMD): clinical trials
Revolution Medicines (RVMD) beyond its filings: 15 active clinical trials.
Revolution Medicines' latest quarter
Revolution Medicines, Q3 2026: revenue $198M, operating margin -188.9%, net loss $407M, operating cash flow −$416M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Revolution Medicines have?
15 active studies on ClinicalTrials.gov, 7 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.